|Articles|January 25, 2008

Once-daily amoxicillin approved

Moxatag is the name of a new once-daily amoxicillin product for pharyngitis and tonsillitis following strep throat

MiddleBrook Pharmaceuticals' Moxatag (amoxicillin extended-release) Tablets 775 mg have been approved to treat adults and children 12 and older with pharyngitis and/or tonsillitis secondary to strep throat. The Germantown, Md., firm claims that its product is the first once-daily amoxicillin product approved in this country. Its convenient dosing should ensure better drug compliance.

 

To see more Daily News articles, click here.

To go to the Drug Topics homepage, .

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.


Latest CME